Head-to-head · WeighScore
HumeCare+ vs Renlo Health
By GLP-1 ScorecardUpdated
Score comparison
Renlo Health has the higher recorded score — 79.7/100 to 58.6/100.
Renlo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs whose headline is the actual monthly rate, with the prescribing physician and the dispensing pharmacy both named.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | HumeCare+ | Renlo Health |
|---|---|---|
| WeighScore | 58.6/100 | 79.7/100 |
| Grade | C | C+ |
| Site position | #328 | #41 |
| Semaglutide | GLP-1 page advertises $199 billed monthly and a first four-week supply; homepage labels a three-month plan from $199/month. Confirm the selected total and formulation additions. | $199/mo, billed monthly at every dose |
| Tirzepatide | Named on the public GLP-1 menu, but no separate current public prescription price confirmed; obtain the selected medication and renewal quote. | $269/mo, billed monthly at every dose |
| Coverage | Homepage/footer exclude Louisiana and Mississippi; GLP-1 FAQ also excludes Alabama. Confirm current treatment-specific eligibility, especially Alabama. | Not publicly listed |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #328 · C
Strengths
- Advertises a Hume Pod and app within the homepage package; other selected plans may differ
- Current terms describe a single subscription including consultation and prescribed fulfilled medication, with added charges requiring disclosure and consent
- Publicly identifies MDI Medical Group PC as the clinical network and provides a clinician directory; assignment and current individual licenses still need confirmation
- Terms allow cancellation before renewal through the account Subscription section or support email
What to consider
- Homepage three-month pricing and the GLP-1 page’s monthly billing description do not establish one selected initial charge or renewal calendar
- Ninety-day, 180-day and six-month results-refund advertisements do not have matching claim rules in the current terms; customer-canceled prepaid periods are not prorated
- Muscle-preservation, side-effect and outcome advantages are merchant claims, not established benefits of the prescribed compound or tracking device
- No exact prescribing dose, vial quantity, usable supply or patient-lab price is confirmed by the public package
- The dispensing pharmacy and physical compounder are not named in the reviewed terms or shipping policy
- Alabama availability differs between the GLP-1 FAQ and site footer; general eligibility does not guarantee every preparation
- Next-day advertising differs from published clinical-review, pharmacy-processing and carrier estimates; a free included device does not create a separate device cash refund
Site position #41 · C+
Strengths
- The headline is the real month-to-month rate — no prepay division and no commitment behind an asterisk
- A genuine all-in line: medication, injection supplies, provider evaluation, ongoing care, expedited shipping and unlimited care-team messaging, with no membership or consultation fees
- Names the prescribing physician, Dr. Sean Arora, MD, and the dispensing pharmacy, VialsRX
- Same price at every dose with a price-lock badge
- A four-month money-back guarantee, and cancel anytime with no fee
What to consider
- A struck-through $399 sits beside the price with no published basis — Renlo never says what it was, when it applied or to whom
- That strikethrough comes from a stylesheet rule rather than a struck-out element, so a markup-level check would report the page clean
- A comparison table headed "Most GLP-1 providers" quotes $270, $365 and $445 by dose while naming no provider and citing no source
- A site-wide $50 code means the advertised figure is not the first amount charged
- No lab protocol is published, and there is no oral or brand route
Featured provider
HumeCare+
HumeCare+ scores 58.6/100 (C). Pairs advertised GLP-1 care with connected body-composition tracking, while public pages differ on payment periods, delivery and refund promises.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.